BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16131428)

  • 21. The role of cytokines in postmenopausal osteoporosis.
    Brincat SD; Borg M; Camilleri G; Calleja-Agius J
    Minerva Ginecol; 2014 Aug; 66(4):391-407. PubMed ID: 25020058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proinflammatory cytokines and osteoporosis.
    McLean RR
    Curr Osteoporos Rep; 2009 Dec; 7(4):134-9. PubMed ID: 19968917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-7 drives T cell-mediated bone loss following ovariectomy.
    Robbie-Ryan M; Pacifici R; Weitzmann MN
    Ann N Y Acad Sci; 2006 Apr; 1068():348-51. PubMed ID: 16831936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells.
    Gao Y; Qian WP; Dark K; Toraldo G; Lin AS; Guldberg RE; Flavell RA; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16618-23. PubMed ID: 15531637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
    Lee EJ; Kim JL; Kim YH; Kang MK; Gong JH; Kang YH
    Phytomedicine; 2014 Sep; 21(10):1208-15. PubMed ID: 24932975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
    Jochems C; Islander U; Erlandsson M; Verdrengh M; Ohlsson C; Carlsten H
    Arthritis Res Ther; 2005; 7(4):R837-43. PubMed ID: 15987485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BMI-1 Mediates Estrogen-Deficiency-Induced Bone Loss by Inhibiting Reactive Oxygen Species Accumulation and T Cell Activation.
    Li J; Wang Q; Yang R; Zhang J; Li X; Zhou X; Miao D
    J Bone Miner Res; 2017 May; 32(5):962-973. PubMed ID: 27943387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses and bone loss: the estrogen connection.
    Carlsten H
    Immunol Rev; 2005 Dec; 208():194-206. PubMed ID: 16313350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency.
    Strait K; Li Y; Dillehay DL; Weitzmann MN
    Int J Mol Med; 2008 Apr; 21(4):521-5. PubMed ID: 18360699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of estrogen down-regulates CXCR4 expression on Treg cells and reduces Treg cell population in bone marrow in OVX mice.
    Fan XL; Duan XB; Chen ZH; Li M; Xu JS; Ding GM
    Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):13-7. PubMed ID: 26025396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL; Khosla S; Melton LJ
    J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen deficiency inducing shifted cytokines profile in bone marrow stromal cells inhibits Treg cells function in OVX mice.
    Zeng QM; Liu DC; Zhang XC; Wu JP; Ding L; Meng DH; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):64-8. PubMed ID: 26025405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and bone metabolism.
    Väänänen HK; Härkönen PL
    Maturitas; 1996 May; 23 Suppl():S65-9. PubMed ID: 8865143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contemporary views on use of estrogen replacement therapy in postmenopausal women. I. Hormone therapy in women with menopausal osteoporosis].
    Krasomski G
    Ginekol Pol; 1995 Jan; 66(1):28-31. PubMed ID: 8522210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental techniques for screening of antiosteoporotic activity in postmenopausal osteoporosis.
    Satpathy S; Patra A; Ahirwar B
    J Complement Integr Med; 2015 Dec; 12(4):251-66. PubMed ID: 26215536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.
    Sunyer T; Lewis J; Collin-Osdoby P; Osdoby P
    J Clin Invest; 1999 May; 103(10):1409-18. PubMed ID: 10330423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17 cells.
    Yu M; Pal S; Paterson CW; Li JY; Tyagi AM; Adams J; Coopersmith CM; Weitzmann MN; Pacifici R
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 7 and estrogen-induced bone loss.
    Ross FP
    Trends Endocrinol Metab; 2003; 14(4):147-9. PubMed ID: 12714270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
    Goldring SR
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii11-6. PubMed ID: 12817090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.